Search for: "KV Pharmaceuticals"
Results 1 - 20
of 92
Sort by Relevance
|
Sort by Date
21 Dec 2018, 9:14 am
KV (Sri Lanka) v Secretary of State for the Home Department was heard on 10 and 11 December 2018. [read post]
7 May 2015, 5:00 am
KV Pharmaceutical Co., 2011 WL 6257466, at *5 (E.D. [read post]
3 Jul 2013, 5:48 am
KV Pharmaceutical). [read post]
24 Oct 2012, 3:51 pm
KV maintains that “[g]iven the status of Makena®’s orphan drug designation and market exclusivity, KV constitutes the entire domestic [HPC] pharmaceutical industry. [read post]
6 Sep 2012, 5:25 pm
District Court for the District of Columbia dealt a blow to K-V Pharmaceutical Company’s (“KV’s”) efforts to “restore” orphan drug exclusivity for the pre-term birth drug MAKENA (hydroxyprogesterone caproate) Injection, 250 mg/mL, by granting FDA’s Motion to Dismiss a case filed by KV back in early July. [read post]
17 Aug 2012, 6:41 am
Louis based KV Pharmaceutical files for Chapter 11 bankruptcy protection after dealing with manufacturing issues along with weak sales of its birth control drug Makena. [read post]
9 Jul 2012, 2:00 am
We also discuss a First Circuit decision affirming the dismissal of a securities fraud action against Textron; a Second Circuit ruling addressing the standard for pleading a failure to disclose “known uncertainties” under Item 303 of Regulation S-K; and an Eighth Circuit decision reversing the dismissal of a securities fraud action against KV Pharmaceutical Company. [read post]
9 Jul 2012, 2:00 am
We also discuss a First Circuit decision affirming the dismissal of a securities fraud action against Textron; a Second Circuit ruling addressing the standard for pleading a failure to disclose “known uncertainties” under Item 303 of Regulation S-K; and an Eighth Circuit decision reversing the dismissal of a securities fraud action against KV Pharmaceutical Company. [read post]
8 Jul 2012, 7:01 pm
Karst – In a rare lawsuit against FDA involving the Orphan Drug Act of 1983, as amended, K-V Pharmaceutical Company (“KV”) and its wholly-owned subsidiary, Ther-Rx Corporation (“Ther-Rx”), filed a Complaint and a Motion for Temporary Restraining Order and Preliminary Injunction in the U.S. [read post]
2 Jul 2012, 6:57 am
Eighth Circuit Court of Appeals ruled that investors can continue to bring claims against KV Pharmaceutical Co. [read post]
20 Jun 2012, 10:00 am
KV Pharmaceutical Company, click here . [read post]
20 Jun 2012, 10:00 am
KV Pharmaceutical Company, click here. [read post]
16 May 2012, 12:22 pm
KV Pharmaceutical Co., 2011 WL 6257466, at *6, 8 (E.D. [read post]
1 Mar 2012, 9:30 pm
KV Pharmaceutical company will pay $17 million for allegedly accepting Medicaid reimbursement for drugs which were deemed “less than effective” by the FDA, and thus were ineligible for reimbursement by federal healthcare programs. [read post]
22 Feb 2012, 12:46 am
In the course of the investigation, K-V discovered it had manufactured additional oversized tablets of other pharmaceuticals. [read post]
19 Feb 2012, 4:31 pm
K-V Pharmaceutical Company, C.A. [read post]
2 Feb 2012, 4:21 am
The whole scene is reminiscent of the March of Dimes / KV Pharmaceuticals / Makena fiasco from March of 2011, in which another well-respected charitable organization lost its way, got involved with the wrong sort of people, and ended up making a wildly irresponsible choice diametrically opposed to the claimed mission of the organization. [read post]
27 Dec 2011, 9:56 am
Janssen Pharmaceuticals, Inc., 951 N.E.2d 1238 (Ill. [read post]
26 Dec 2011, 12:37 pm
KV Pharmaceuticals Co., 2011 WL 6257466 (E.D. [read post]
22 Dec 2011, 11:59 am
KV Pharmaceutical Co., 2011 WL 6257466 (E.D. [read post]
